A non-nephrotoxic gentamicin congener that retains antimicrobial efficacy

Journal of the American Society of Nephrology

Volumn 17, Issue 10, 2006, Pages 2697-2705

  Sandoval, Ruben M ^a   Reilly, James P ^d   Running, William ^d   Campos, Silvia B ^a   Santos, Joseph R ^a   Phillips, Carrie L ^a,b   Molitoris, Bruce A ^a,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; KANAMYCIN A; NEBRAMYCIN; TOBRAMYCIN;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACILLUS SUBTILIS; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; GENE MUTATION; GRAM NEGATIVE INFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERNALIZATION; KLEBSIELLA PNEUMONIAE; MALE; MULTIDRUG RESISTANCE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 33749246243     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005101124     Document Type: Article

References (26)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310, 2001
2. Thakar CV, Yared JP, Worley S, Cotman K, Paganini EP: Renal dysfunction and serious infections after open-heart surgery. Kidney Int 64: 239-246, 2003
3. Ridley RG: Research on infectious diseases requires better coordination. Nat Med 10[Suppl]: S137-S140, 2004
4. Levy SB, Marshall B: Antibacterial resistance worldwide: Causes, challenges and responses. Nat Med 10[Suppl]: S122-S129, 2004
5. Molitoris BA: Cell biology of aminoglycoside nephrotoxicity: Newer aspects. Curr Opin Nephrol Hypertens 6: 384-388, 1997
6. Smith CR, Moore RD, Lietman PS: Studies of risk factors for aminoglycoside nephrotoxicity. Am J Kidney Dis 8: 308-313, 1986
7. Schmitz C, Hilpert J, Jacobsen C, Boensch C, Christensen EI, Luft FC, Willnow TE: Megalin deficiency offers protection from renal aminoglycoside accumulation. J Biol Chem 277: 618-622, 2002
8. Wilschanski M, Yahav Y, Yaacov Y, Blau H, Bentur L, Rivlin J, Aviram M, Bdolah-Abram T, Bebok Z, Shushi L, Kerem B, Kerem E: Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. N Engl J Med 349: 1433-1441, 2003
9. Sandoval RM, Molitoris BA: Gentamicin traffics retrograde through the secretory pathway and is released in the cytosol via the endoplasmic reticulum. Am J Physiol Renal Physiol 286: F617-F624, 2004
10. Moestrup SK, Cui S, Vorum H, Bregengard C, Bjorn SE, Norris K, Gliemann J, Christensen EI: Evidence that epithelial glycoprotein 330/megalin mediates uptake of poly-basic drugs. J Clin Invest 96: 1404-1413, 1995
11. Saito A, Pietromonaco S, Loo AK, Farquhar MG: Complete cloning and sequencing of rat gp330/"megalin," a distinctive member of the low density lipoprotein receptor gene family. Proc Natl Acad Sci U S A 91: 9725-9729, 1994
12. Kohlhepp SJ, Loveless MO, Kohnen PW, Houghton DC, Bennett WM, Gilbert DN: Nephrotoxicity of the constituents of the gentamicin complex. J Infect Dis 149: 605-614, 1984
13. Jablonski P, Howden BO, Rae DA, Birrell CS, Marshall VC, Tange J: An experimental model for assessment of renal recovery from warm ischemia. Transplantation 35: 198-204, 1983
14. Houghton DC, Hartnett M, Campbell-Boswell M, Porter G, Bennett W: A light and electron microscopic analysis of gentamicin nephrotoxicity in rats. Am J Pathol 82: 589-612, 1976
15. Beauchamp D, Gourde P, Bergeron MG: Subcellular distribution of gentamicin in proximal tubular cells, determined by immunogold labeling. Antimicrob Agents Chemother 35: 2173-2179, 1991
16. Servais H, Van Der Smissen P, Thirion G, Van der Essen G, Van Bambeke F, Tulkens PM, Mingeot-Leclercq MP: Gentamicin-induced apoptosis in LLC-PK1 cells: Involvement of lysosomes and mitochondria. Toxicol Appl Pharmacol 206: 321-333, 2005
17. Pavelka M, Ellinger A: Localization of binding sites for concanavalin A, Ricinus communis 1 and Helix pomatia lectin in the Golgi apparatus of rat small intestinal absorptive cells. J Histochem Cytochem 33: 905-914, 1985
18. Bennett WM, Elliott WC, Houghton DC, Gilbert DN, DeFehr J, McCarron DA: Reduction of experimental gentamicin nephrotoxicity in rats by dietary calcium loading. Antimicrob Agents Chemother 22: 508-512, 1982
19. Swan SK, Kohlhepp SJ, Kohnen PW, Gilbert DN, Bennett WM: Long-term protection of polyaspartic acid in experimental gentamicin nephrotoxicity. Antimicrob Agents Chemother 35: 2591-2595, 1991
20. Whittem T, Schnellmann RG, Ferguson DC: Poly-L-aspartic acid does but triiodothyronine does not protect against gentamicin-induced cytotoxicity in the porcine kidney cell line LLC-PK1. J Pharmacol Exp Ther 262: 834-840, 1992
21. Kishore BK, Lambricht P, Laurent G, Maldague P, Wagner R, Tulkens PM: Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids. J Pharmacol Exp Ther 255: 875-885, 1990
22. Beauchamp D, Laurent G, Maldague P, Abid S, Kishore BK, Tulkens PM: Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid. J Pharmacol Exp Ther 255: 858-866, 1990
23. Budavari S, O'Neil M, Smith A, Heckelman P: The Merck Index, 11th Ed., Merck & Co., Inc., 1989
24. Keeling KM, Bedwell DM: Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system. J Mol Med 80: 367-376, 2002
25. Lippincott-Schwartz J, Yuan L, Tipper C, Amherdt M, Orci L, Klausner RD: Brefeldin A's effects on endosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic. Cell 67: 601-616, 1991
26. Sandoval RM, Dunn KW, Molitoris BA: Gentamicin traffics rapidly and directly to the Golgi complex in LLC-PK(1) cells. Am J Physiol Renal Physiol 279: F884-F890, 2000